Wu‐tong Ju

A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma

Wu‐tong Ju, Ronghui Xia, Dongwang Zhu et al. · Nature Communications · 2022 · 121 citations · Full text

Medicine, Oncology, Pharmacology +17

Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial)

Yingying Huang, Jingjing Sun, Jun Li et al. · International Journal of Surgery · 2023 · 69 citations · Full text

Medicine, Immunology, Oncology +17

Overcoming chemotherapy resistance using pH-sensitive hollow MnO2 nanoshells that target the hypoxic tumor microenvironment of metastasized oral squamous cell carcinoma

Zhi-Hang Zhou, Siyuan Liang, Tongchao Zhao et al. · Journal of Nanobiotechnology · 2021 · 56 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response

Mei Zhao, Tianxiao Wang, Frederico O. Gleber‐Netto et al. · Nature Communications · 2024 · 48 citations · Full text

Medicine, Genetics, Oncology +17

Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma

Hailong Ma, Shufang Jin, Wu‐tong Ju et al. · Journal of Experimental & Clinical Cancer Research · 2017 · 35 citations · Full text

Medicine, Molecular Biology, Oncology +17